ETHZilla Corporation Common Stock ATNF
Set alert
7.04 0.00 0.00%
At close · Aug 15
6.29 Day range 7.24
52-week range unavailable
- YTD
- +286.81%
- 1 year
- +264.77%
- Open
- 6.84
- Prev close
- 7.04
- Mkt cap
- 5.73M
- Vol
- 11.63M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.29
- High
- 7.24
- Forward P/E
- -6.30
- Beta
- 0.25
- Short ratio
- 0.03
- Inst. own
- 3.45%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.87
- 200-d avg
- 2.20
- 1y target
- 0.00
2Y chart
Events in this range
- Feb 28, 2024Split: 1 for 19
Signals (92)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Aug 12, 2025 | 1 year ago |
| RSI: Overbought | Aug 12, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 11, 2025 | 1 year ago |
| RSI: Overbought | Aug 6, 2025 | 1 year ago |
| RSI: Overbought | Jul 25, 2025 | 1 year ago |
| SMA: Bullish | Jul 17, 2025 | 1 year ago |
| SMA: Bullish | Jul 17, 2025 | 1 year ago |
| RSI: Overbought | Jul 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 10, 2025 | 1 year ago |
| SMA: Bearish | Jun 13, 2025 | 1 year ago |
| SMA: Bullish | Jun 12, 2025 | 1 year ago |
| SMA: Bearish | Jun 11, 2025 | 1 year ago |
| SMA: Bullish | May 27, 2025 | 1 year ago |
| SMA: Bearish | May 23, 2025 | 1 year ago |
| MACD: Sell Signal | May 22, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2025 | 1 year ago |
| RSI: Overbought | May 1, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 15, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 3, 2025 | 1 year ago |
| RSI: Oversold | Apr 3, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 2, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 1, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 3, 2025 | 1 year ago |
| SMA: Bearish | Dec 27, 2024 | 1 year ago |
| SMA: Bullish | Dec 24, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 20, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 12, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 11, 2024 | 1 year ago |
| SMA: Bearish | Dec 3, 2024 | 1 year ago |
| SMA: Bullish | Dec 2, 2024 | 1 year ago |
| SMA: Bearish | Nov 18, 2024 | 1 year ago |
| SMA: Bearish | Nov 15, 2024 | 1 year ago |
| MACD: Sell Signal | Oct 31, 2024 | 2 years ago |
| SMA: Bullish | Oct 16, 2024 | 2 years ago |
| SMA: Bullish | Oct 16, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 16, 2024 | 2 years ago |
| RSI: Overbought | Oct 16, 2024 | 2 years ago |
| RSI: Oversold | Oct 8, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 24, 2024 | 2 years ago |
| SMA: Bearish | Sep 19, 2024 | 2 years ago |
| SMA: Bullish | Sep 18, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 18, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 10, 2024 | 2 years ago |
| SMA: Bearish | Sep 5, 2024 | 2 years ago |
| SMA: Bullish | Sep 4, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 4, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 30, 2024 | 2 years ago |
| SMA: Bearish | Aug 29, 2024 | 2 years ago |
| SMA: Bullish | Aug 28, 2024 | 2 years ago |
| SMA: Bearish | Aug 27, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 22, 2024 | 2 years ago |
| SMA: Bullish | Aug 21, 2024 | 2 years ago |
| SMA: Bearish | Aug 20, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| SMA: Bearish | Aug 16, 2024 | 2 years ago |
| SMA: Bullish | Aug 15, 2024 | 2 years ago |
| SMA: Bearish | Aug 2, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 29, 2024 | 2 years ago |
| SMA: Bullish | Jul 9, 2024 | 2 years ago |
| RSI: Overbought | Jul 9, 2024 | 2 years ago |
| MACD: Buy Signal | May 31, 2024 | 2 years ago |
| MACD: Sell Signal | May 24, 2024 | 2 years ago |
| MACD: Buy Signal | May 21, 2024 | 2 years ago |
| MACD: Sell Signal | May 20, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 19, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 16, 2024 | 2 years ago |
| RSI: Oversold | Apr 16, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 9, 2024 | 2 years ago |
| RSI: Oversold | Mar 26, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 18, 2024 | 2 years ago |
| SMA: Bearish | Mar 13, 2024 | 2 years ago |
| SMA: Bearish | Mar 8, 2024 | 2 years ago |
| SMA: Bullish | Mar 7, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 6, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 23, 2024 | 2 years ago |
| SMA: Bearish | Feb 21, 2024 | 2 years ago |
| SMA: Bullish | Feb 20, 2024 | 2 years ago |
| SMA: Bearish | Feb 16, 2024 | 2 years ago |
| SMA: Bullish | Feb 14, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 8, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 7, 2024 | 2 years ago |
| SMA: Bearish | Jan 11, 2024 | 2 years ago |
| SMA: Bullish | Jan 10, 2024 | 2 years ago |
| MACD: Buy Signal | Dec 22, 2023 | 2 years ago |
| RSI: Oversold | Dec 15, 2023 | 2 years ago |
| RSI: Oversold | Dec 11, 2023 | 2 years ago |
| MACD: Sell Signal | Nov 22, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 16, 2023 | 2 years ago |
| MACD: Sell Signal | Nov 15, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 10, 2023 | 2 years ago |
| RSI: Oversold | Nov 7, 2023 | 2 years ago |
Key statistics
- Market cap
- 5.73M
- Enterprise value
- 1.72M
- Trailing P/E
- 0.36
- Forward P/E
- -6.30
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 7.98
- Beta
- 0.25
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -4.45M
- Total cash
- 1.15M
- Total debt
- 442.29K
- Return on equity
- -398.58%
- Shares outstanding
- 1.98M
- Short % of float
- 13.68%
- 50-day average
- 2.87
- 200-day average
- 2.20
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
ATNF Revenue — quarterly 0
ATNF Net income — quarterly -1.73M
ATNF EPS — quarterly -0.30
About ETHZilla Corporation Common Stock
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, that focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Palo Alto, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- 180lifesciences.com
News
- EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank?
- Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
- Stock Market Today: S&P 500, Nasdaq 100 Futures Trade Mixed— UnitedHealth, 180 Life Sciences, Intel In Focus
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Intapp Posts Better-Than-Expected Earnings, Joins Sapiens International, Arcturus Therapeutics, Gildan Activewear And Other Big Stocks Moving Higher On Wednesday
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Why Sapiens International Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
- Stock Market Today: S&P 500, Nasdaq Futures Advance After Hitting Fresh Record—CoreWeave, Cisco, CarParts.Com Earnings In Focus
- Palantir co-founder Peter Thiel buys into crypto firm as stock soars 250%
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
Your note
Sign in to keep a note on ATNF — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FELDMANN MARC | Director | Stock Award(Grant) | Dec 27, 2023 | 250,874 |
| GOLD LAWRENCE M | Director | Stock Award(Grant) | Aug 31, 2023 | 24,745 |
| MARRONE PAMELA G | Director | Stock Award(Grant) | Aug 31, 2023 | 34,857 |
| MCGOVERN DONALD A JR. | Director | Stock Award(Grant) | Aug 31, 2023 | 55,285 |
| PAMIR OZAN | Chief Financial Officer | Purchase | May 17, 2023 | 8,983 |
| RAY RUSSELL T | Director | Stock Award(Grant) | Aug 31, 2023 | 24,409 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Virtu Financial LLC | 0.71% | 14,088 | 40.85K | Sep 29, 2024 |
| UBS Group AG | 0.35% | 6,847 | 19.86K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.12% | 2,335 | 6.77K | Sep 29, 2024 |
| Blackrock Inc. | 0.03% | 564 | 1.64K | Sep 29, 2024 |
| Bank of America Corporation | 0.00% | 7 | 20 | Sep 29, 2024 |
| Semmax Financial Advisors Inc. | 0.00% | 1 | 2 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.24% | 4,649 | 13.48K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.13% | 2,521 | 7.31K | Sep 29, 2024 |
| Fidelity Total Market Index Fund | 0.01% | 102 | 295 | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.00% | 77 | 223 | Oct 30, 2024 |